At Sweden’s annual life science conference, stakeholders from healthcare, academia, and industry discussed implementing the ...

Japan’s Eisai and US partner Biogen have announced today update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab (trade name Leqembi) as a treatment for early ...